PHARMACOKINETIC AND MICROBIAL SUSCEPTIBILITY STUDIES OF CEFTRIAXONE

被引:12
作者
BAUMGARTNER, JD [1 ]
GLAUSER, MP [1 ]
机构
[1] CHU VAUDOIS,DEPT INTERNAL MED,DIV INFECT DIS,CH-1011 LAUSANNE,SWITZERLAND
关键词
D O I
10.1007/BF02013916
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:501 / 504
页数:4
相关论文
共 9 条
[1]  
BAUMGARTNER JD, 1983, ARCH INTERNAL MED
[2]  
BROWN RM, 1982, CURRENT CHEMOTHERAPY, P457
[3]   COMPARATIVE INVITRO STUDIES OF RO-13-9904, A NEW CEPHALOSPORIN DERIVATIVE [J].
EICKHOFF, TC ;
EHRET, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (03) :435-442
[4]  
Gavan T. L., 1980, MANUAL CLIN MICROBIO, P459
[5]   INVITRO EVALUATION OF RO 13-9904 [J].
HINKLE, AM ;
BODEY, GP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (04) :574-578
[6]   ANTI-BACTERIAL ACTIVITY OF CEFTRIAXONE (RO 13-9904), A BETA-LACTAMASE-STABLE CEPHALOSPORIN [J].
NEU, HC ;
MEROPOL, NJ ;
FU, KP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (03) :414-423
[7]   PHARMACOKINETICS OF CEFTRIAXONE IN HUMANS [J].
PATEL, IH ;
CHEN, S ;
PARSONNET, M ;
HACKMAN, MR ;
BROOKS, MA ;
KONIKOFF, J ;
KAPLAN, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (05) :634-641
[8]  
Sabath LD, 1980, MANUAL CLIN MICROBIO, P485
[9]   INVITRO ANTI-BACTERIAL ACTIVITY AND SUSCEPTIBILITY OF THE CEPHALOSPORIN RO 13-9904 TO BETA-LACTAMASES [J].
SHANNON, K ;
KING, A ;
WARREN, C ;
PHILLIPS, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (02) :292-298